Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes by Hägg S, Spigset O, Lakso H A, Dahlqvist R in European journal of clinical pharmacology (2001).

[PMID: 11699614] PubMed


Limited data suggest that CYP1A2 and CYP2D6 are involved in the metabolism of olanzapine. The purpose of this study was to further elucidate the role of these enzymes in the disposition of olanzapine in vivo.

[ hide abstract ]

Discussed In Paper


Variant Annotations

Sign in to see variant annotations.

Dosing Information

No dosing information annotated.